Related Experiment Video
Updated: Aug 11, 2026
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Management of neonatal hyperbilirubinemia: pediatricians' practices and educational needs
Anna Petrova1, Rajeev Mehta, Gillian Birchwood
1Division of Neonatology, Department of Pediatrics, Robert Wood Johnson Medical School-University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey 08903, USA. petroran@umdnj.edu
Insights
New Jersey pediatricians often underestimate jaundice risk factors and initiate phototherapy below recommended levels, impacting neonatal hyperbilirubinemia management. Early detection and adherence to guidelines are crucial for preventing bilirubin-induced encephalopathy.
Area of Science:
- Neonatology
- Pediatrics
- Public Health
Background:
- Neonatal hyperbilirubinemia requires early detection and treatment to prevent bilirubin-induced encephalopathy.
- The American Academy of Pediatrics (AAP) established guidelines in 1994 for managing this condition.
Purpose of the Study:
- To evaluate New Jersey pediatricians' practices and beliefs concerning neonatal hyperbilirubinemia management.
- To assess compliance with the 1994 AAP recommendations for neonatal hyperbilirubinemia treatment.
Main Methods:
- A survey questionnaire was distributed to 800 New Jersey pediatricians.
- The survey assessed diagnostic, treatment, and follow-up practices, as well as beliefs on risk factors for severe hyperbilirubinemia.
Main Results:
- A 49.1% adjusted response rate was achieved (n=356).
- Pediatricians reported low utilization of transcutaneous bilirubinometry (16.1%) and variable adherence to AAP phototherapy guidelines, particularly for infants under 72 hours.
- Post-discharge TSB testing was less frequently indicated (57.7%) compared to pre-discharge (87.4%).
Conclusions:
- Pediatricians' practices show low utilization of laboratory diagnosis post-discharge and underestimate certain risk factors.
- Initiation of phototherapy at lower than recommended TSB levels was observed.
- Neonatal hyperbilirubinemia is recognized as a significant public health concern, necessitating improved adherence to established guidelines.
Background:
Early detection and treatment of neonatal hyperbilirubinemia is important in the prevention of bilirubin-induced encephalopathy. In this study, we evaluated the New Jersey pediatricians' practices and beliefs regarding the management of neonatal hyperbilirubinemia and their compliance with the recommendations made by the American Academy of Pediatrics (AAP) in 1994.
Methods:
A survey questionnaire was mailed to a random sample of 800 pediatricians selected from a list of 1623 New Jersey Fellows of the AAP initially in October 2003 and then in February 2004 for the non-respondents. In addition to the physicians' demographic characteristics, the questionnaire addressed various aspects of neonatal hyperbilirubinemia management including the diagnosis, treatment, and follow up as well as the pediatricians' beliefs regarding the significance of risk factors in the development of severe hyperbilirubinemia.
Results:
The adjusted response rate of 49.1% (n = 356) was calculated from the 725 eligible respondents. Overall, the practicing pediatricians reported high utilization (77.9%) of the cephalocaudal progression of jaundice and low utilization (16.1%) of transcutaneous bilirubinometry for the quantification of the severity of jaundice. Most of the respondents (87.4%) identified jaundice as an indicator for serum bilirubin (TSB) testing prior to the neonate's discharge from hospital, whereas post-discharge, only 57.7% felt that a TSB was indicated (P < 0.01). If the neonate's age was under 72 hours, less than one-third of the respondents reported initiation of phototherapy at TSB levels lower than the treatment parameters recommended by the AAP in 1994, whereas if the infant was more than 72 hours old, almost 60% were initiating phototherapy at TSB lower than the 1994 AAP guidelines. Most respondents did not regard neonatal jaundice noted after discharge and gestational ages 37-38 weeks as being significant in the development of severe hyperbilirubinemia. However, the majority did recognize the importance of jaundice presenting within the first 24 hours and Rh/ABO incompatibility.
Conclusion:
The pediatricians' practices regarding the low utilization of laboratory diagnosis for the quantification of jaundice after discharge and underestimation of risk factors that contribute to the development of severe hyperbilirubinemia are associated with initiation of phototherapy at lower than AAP recommended treatment parameters and recognition of neonatal hyperbilirubinemia as an important public health concern.
Related Concept Videos
01:25Jaundice
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:19Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...